Macroaxis is not in business of monitoring St Jude headlines and social sentiment data; there are plenty of companies out there that do it quite successfully. However, we do analyze noise-free headlines and recent hype associated with St Jude Medical brand which may create opportunities for some arbitrage if properly timed. With St Jude hype-based prediction module you can estimate the value of St Jude Medical from the prospective of St Jude response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on St Jude over a specific investment horizon. Also please take a look at St Jude Basic Forecasting Models to cross-verify your projections.
On 23 of June St Jude Medical is traded for 80.82. This company stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. St Jude Medical is estimated not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 0.0%. The immediate return on the next news is estimated to be very small where as daily expected return is at this time at 0.0%. The volatility of relative hype elasticity to St Jude is about 0.0%%. The volatility of related hype on St Jude is about 0.0% with expected price after next announcement by competition of 80.82. About 86.0% of the company shares are owned by institutional investors. The company last dividend was issued on September 28, 2016. St Jude Medical had 2:1 split on November 23, 2004. Considering 30-days investment horizon, the next estimated press release will be within a week. Also please take a look at St Jude Basic Forecasting Models to cross-verify your projections.